Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01089049 | Effect of a Natural Health Product on Urinary Estrogen Metabolites | completed | Phase 1 / Phase 2 | 98 | Nutrasource Pharmaceutical and Nutraceutical Services, Inc.NETWORK | 1 | Mar 26, 2012 | clinicaltrials |
| NCT00019812 | Monoclonal Antibody Plus Chemotherapy in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2 | completed | Phase 2 | 55 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 23, 2012 |
| clinicaltrials |
| NCT00149214 | Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment Regimens | completed | Phase 2 | 257 | Eli Lilly and CompanyINDUSTRY | 4 | Mar 21, 2012 | clinicaltrials |
| NCT00454532 | A Phase I/II Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 27 | BionovoINDUSTRY | 0 | Mar 16, 2012 | clinicaltrials |
| NCT00721747 | Taxotere®, Followed by Myocet® and Cyclophosphamide First Line Treatment in HER2 Neg Breast Cancer | unknown | Phase 2 | 83 | Grupo Oncológico GallegoOTHER | 1 | Mar 16, 2012 | clinicaltrials |
| NCT00657137 | APRiCOT-B: Study to Evaluate Apricoxib in Combination With Lapatinib and Capecitabine in the Treatment of HER2/Neu+ Breast Cancer (TP2001-202)(APRiCOT-B) | terminated | Phase 2 | 12 | Tragara Pharmaceuticals, Inc.INDUSTRY | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00739063 | Phase II Study of Erlotinib, an EGFR Inhibitor in Metastatic EGFR-positive 'Triple Receptor-negative' Breast Cancer | terminated | Phase 2 | 11 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00453635 | Study With Docetaxel, Carboplatin and Herceptin Versus Vinorelbine and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients | terminated | Phase 2 | 88 | Hellenic Oncology Research GroupOTHER | 1 | Mar 13, 2012 | clinicaltrials |
| NCT00002585 | Pyrazoloacridine in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | 20 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Mar 12, 2012 | clinicaltrials |
| NCT00064311 | Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation | completed | Phase 1 / Phase 2 | — | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00301899 | Trastuzumab and Pertuzumab in Treating Patients With Unresectable Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Trastuzumab | completed | Phase 2 | 37 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 8, 2012 | clinicaltrials |
| NCT00233974 | Molecular Marker Profiling of Axillary Lymph Nodes in Predicting Response in Patients With Locally Advanced or Metastatic Breast Cancer Who Are Undergoing Chemotherapy Followed By Surgery | completed | Phase 2 | 15 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Mar 7, 2012 | clinicaltrials |
| NCT00955890 | Dexrazoxane as a Protective Agent in Anthracycline Treated Breast Cancer(cardioprotec) | terminated | Phase 2 | 12 | Fudan UniversityOTHER | 1 | Feb 28, 2012 | clinicaltrials |
| NCT00003392 | High-Dose Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer | completed | Phase 2 | 61 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Feb 22, 2012 | clinicaltrials |
| NCT00305448 | A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg (Plus 250mg Loading Regimen) and 500mg(FINDER I) | completed | Phase 2 | 143 | AstraZenecaINDUSTRY | 1 | Feb 15, 2012 | clinicaltrials |
| NCT00214864 | A Study of Weekly Taxotere and Xeloda in Metastatic Breast Cancer | completed | Phase 2 | 18 | Cancer Research NetworkOTHER | 1 | Feb 14, 2012 | clinicaltrials |
| NCT00907959 | A Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer | unknown | Phase 2 | 80 | BionovoINDUSTRY | 1 | Feb 8, 2012 | clinicaltrials |
| NCT01528826 | Salvage Chemotherapy of Vinorelbine Plus Oxaliplatin in Metastatic Triple-negative Breast Cancer:a Prospective Trial(NVBOX) | unknown | Phase 2 | 35 | Fudan UniversityOTHER | 1 | Feb 8, 2012 | clinicaltrials |
| NCT00006108 | Capecitabine, Paclitaxel, and Trastuzumab in Treating Patients With Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | — | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Feb 7, 2012 | clinicaltrials |
| NCT01526499 | Docetaxel With or Without Metronomic Cyclophosphamide as First Line Chemotherapy in Metastatic Breast Cancer | unknown | Phase 2 | 60 | Fudan UniversityOTHER | 1 | Feb 7, 2012 | clinicaltrials |
| NCT01526512 | Low Dose of Metronomic Cyclophosphamide and Capecitabine in Pretreated HER2-negative Metastatic Breast Cancer | unknown | Phase 2 | 72 | Fudan UniversityOTHER | 1 | Feb 7, 2012 | clinicaltrials |
| NCT01108315 | Comprehensive Patient Reported Outcomes (PRO) Management for Oncology Practice | completed | Phase 1 / Phase 2 | 138 | BrightOutcomeINDUSTRY | 1 | Feb 6, 2012 | clinicaltrials |
| NCT00206466 | Biologic Correlative Taxotere/AC(TAX/AC) | completed | Phase 2 | 70 | Baylor Breast Care CenterOTHER | 1 | Jan 25, 2012 | clinicaltrials |
| NCT01254136 | Safety and Efficacy of INCB007839 With Trastuzumab and Vinorelbine in Patients With Metastatic HER2+ Breast Cancer | terminated | Phase 1 / Phase 2 | 20 | Incyte CorporationINDUSTRY | 1 | Jan 25, 2012 | clinicaltrials |
| NCT01483300 | Effectiveness and Toxicity of Gemcitabine/Lobaplatin Versus Gemcitabine/Cisplatin as Second-line Treatment in Metastatic Breast Cancer | unknown | Phase 2 | 80 | Harbin Medical UniversityOTHER | 1 | Jan 24, 2012 | clinicaltrials |
| NCT01292408 | Autophagy Inhibition Using Hydrochloroquine in Breast Cancer Patients | unknown | Phase 2 | 20 | Radboud University Medical CenterOTHER | 1 | Jan 20, 2012 | clinicaltrials |
| NCT00623233 | Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast Cancer | completed | Phase 2 | 52 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 9, 2012 | clinicaltrials |
| NCT00532857 | Phase II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Trastuzumab(PGH) | completed | Phase 2 | 53 | Jungsil RoOTHER_GOV | 1 | Jan 4, 2012 | clinicaltrials |
| NCT01070706 | Phase Ib/II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Sunitinib(PGS) | completed | Phase 1 / Phase 2 | 15 | Jungsil RoOTHER_GOV | 1 | Jan 4, 2012 | clinicaltrials |
| NCT01169870 | Genexol-PM Versus Paclitaxel in Anthracycline-pretreated Metastatic Breast Cancer Patients | withdrawn | Phase 2 | 0 | National Cancer Center, KoreaOTHER_GOV | 0 | Jan 4, 2012 | clinicaltrials |
| NCT01229605 | Cyclophosphamide and Docetaxel Every 3 Weeks as Neoadjuvant Therapy in Locally Advanced Breast Cancer | withdrawn | Phase 2 | 0 | Tufts Medical CenterOTHER | 0 | Dec 12, 2011 | clinicaltrials |
| NCT01100489 | Breast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast Cancer | withdrawn | Phase 2 | 0 | Case Comprehensive Cancer CenterOTHER | 1 | Dec 8, 2011 | clinicaltrials |
| NCT00760370 | Comparison of Zometa Retention and Effect in Multiple Myeloma and Breast Cancer | completed | Phase 2 | 60 | Vejle HospitalOTHER | 1 | Dec 7, 2011 | clinicaltrials |
| NCT00003887 | Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation | completed | Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Nov 30, 2011 | clinicaltrials |
| NCT00206505 | Neoadjuvant Taxotere | completed | Phase 2 | 40 | Baylor Breast Care CenterOTHER | 1 | Nov 17, 2011 | clinicaltrials |
| NCT01276769 | Comparison Study of Neoadjuvant Paclitaxel Plus Carboplatin/Epirubicin Treatment in Triple-negative Breast Cancer | unknown | Phase 2 | 80 | Chinese Academy of Medical SciencesOTHER | 1 | Nov 16, 2011 | clinicaltrials |
| NCT00028483 | Monoclonal Antibody Therapy and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer | terminated | Phase 2 | — | Seagen Inc.INDUSTRY | 1 | Oct 24, 2011 | clinicaltrials |
| NCT01451580 | Lipo-dox and Cyclophosphamide /5-Fluorouracil in Patients With Metastatic Breast Cancer | unknown | Phase 2 | 47 | TTY BiopharmINDUSTRY | 1 | Oct 13, 2011 | clinicaltrials |
| NCT00196820 | Mono Efficacy of Capecitabine (MoniCa) | completed | Phase 2 | 200 | GBG Forschungs GmbHOTHER | 1 | Oct 6, 2011 | clinicaltrials |
| NCT01439191 | Study of Cipterbin®, Used Alone or With Vinorelbine in Patients With HER2/Neu-overexpressed Metastatic Breast Cancer | completed | Phase 2 | 109 | Shanghai CP Guojian Pharmaceutical Co., Ltd.INDUSTRY | 1 | Sep 23, 2011 | clinicaltrials |
| NCT01423695 | Weekly Paclitaxel and Trastuzumab in Metastatic Breast Cancer | completed | Phase 2 | 121 | WiSP Wissenschaftlicher Service Pharma GmbHOTHER | 1 | Aug 26, 2011 | clinicaltrials |
| NCT01422551 | Facilitating Positive Adaptation to Breast Cancer | completed | Phase 2 | 240 | University of MiamiOTHER | 1 | Aug 24, 2011 | clinicaltrials |
| NCT00795899 | Taxol Epirubicin Cyclophosphamide Herceptin Neoadjuvant (TECHNO) | completed | Phase 2 | 230 | GBG Forschungs GmbHOTHER | 1 | Aug 16, 2011 | clinicaltrials |
| NCT01415336 | AX Versus AC as Adjuvant Treatment for Node-Negative Breast Cancer | unknown | Phase 2 / Phase 3 | 300 | Peking Union Medical College HospitalOTHER | 1 | Aug 11, 2011 | clinicaltrials |
| NCT00602108 | Radiation Therapy in Treating Women Undergoing Lumpectomy for Stage I or Stage IIA Breast Cancer | completed | Phase 2 | 50 | Mayo ClinicOTHER | 0 | Aug 10, 2011 | clinicaltrials |
| NCT00515762 | Prevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling | completed | Phase 2 | 150 | Hospital San Carlos, MadridOTHER | 1 | Aug 9, 2011 | clinicaltrials |
| NCT00028639 | PS-341 in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jul 29, 2011 | clinicaltrials |
| NCT00927511 | A Study, Comparing a Dose-Titration Regimen of Fulvestrant With the Approved Dosing Regimen in Postmenopausal Patients With Hormone-Responsive Advanced Breast Cancer (ABC)(FIDeS) | unknown | Phase 2 | 104 | Regina Elena Cancer InstituteOTHER | 1 | Jul 22, 2011 | clinicaltrials |
| NCT00429247 | Randomized Trial With Trastuzumab Versus Observation in Breast Cancer Patients | completed | Phase 2 | 75 | University Hospital of CreteOTHER | 1 | Jul 21, 2011 | clinicaltrials |
| NCT01395706 | ICG Fluorescence Technique for the Detection of Sentinel Lymph Nodes | unknown | Phase 2 | 125 | Pulsion Medical Systems SEINDUSTRY | 1 | Jul 18, 2011 | clinicaltrials |
Data updated 24 days agoSource updated Mar 26, 2012source: clinicaltrials